Compugroup Medical Se Stock Net Income
| COP Stock | EUR 25.48 0.46 1.84% |
Fundamental analysis of Compugroup Medical allows traders to better anticipate movements in Compugroup Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Compugroup |
Compugroup Medical SE Company Net Income Analysis
Compugroup Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Compugroup Medical Net Income | 68.97 M |
Most of Compugroup Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Compugroup Medical SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Compugroup Medical SE reported net income of 68.97 M. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The net income for all Germany stocks is notably lower than that of the firm.
Compugroup Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Compugroup Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Compugroup Medical could also be used in its relative valuation, which is a method of valuing Compugroup Medical by comparing valuation metrics of similar companies.Compugroup Medical is currently under evaluation in net income category among its peers.
Compugroup Fundamentals
| Current Valuation | 2.74 B | |||
| Price To Book | 2.94 X | |||
| Price To Sales | 1.82 X | |||
| Revenue | 1.03 B | |||
| EBITDA | 213.99 M | |||
| Net Income | 68.97 M | |||
| Total Debt | 587.08 M | |||
| Cash Flow From Operations | 165.27 M | |||
| Market Capitalization | 3.3 B | |||
| Total Asset | 1.79 B | |||
| Z Score | 3.0 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 1.79 B | |||
| Last Dividend Paid | 0.5 |
About Compugroup Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Compugroup Medical SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compugroup Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compugroup Medical SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.